| Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer (NCT00025389) | University of Chicago | 2001-11-01 |
| Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease (NCT00084409) | University of Colorado, Denver | 2001-11-01 |
| Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00025272) | Wake Forest University Health Sciences | 2001-11-01 |
| Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00025285) | Wake Forest University Health Sciences | 2001-11-01 |
| Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer (NCT00030641) | Genta Incorporated | 2001-10-01 |
| Concomitant Tracheostomy and Lung Resection (NCT01053624) | University Hospital, Clermont-Ferrand | 2001-10-01 |
| Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer (NCT00030407) | Barbara Ann Karmanos Cancer Institute | 2001-10-01 |
| Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00030420) | Barbara Ann Karmanos Cancer Institute | 2001-10-01 |
| Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer (NCT00387660) | University of California, Davis | 2001-10-01 |
| Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00041015) | Case Comprehensive Cancer Center | 2001-09-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00033696) | Alliance for Clinical Trials in Oncology | 2001-09-01 |
| Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC (NCT00030810) | Swiss Cancer Institute | 2001-09-01 |
| Iscar for Supplemental Care in Stage IV Lung Cancer (NCT00079794) | National Center for Complementary and Integrative Health (NCCIH) | 2001-09-01 |
| Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00054392) | Fox Chase Cancer Center | 2001-09-01 |
| Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer (NCT00340847) | National Cancer Institute (NCI) | 2001-08-09 |
| Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients (NCT00193323) | SCRI Development Innovations, LLC | 2001-08-01 |
| Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00025480) | Abramson Cancer Center at Penn Medicine | 2001-08-01 |
| Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer (NCT00005850) | Alliance for Clinical Trials in Oncology | 2001-08-01 |
| Pemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00022646) | Alliance for Clinical Trials in Oncology | 2001-08-01 |
| Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00023673) | Radiation Therapy Oncology Group | 2001-07-01 |
| Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00022009) | The Christie NHS Foundation Trust | 2001-07-01 |
| A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer (NCT00047736) | Genentech, Inc. | 2001-07-01 |
| Genetic Epidemiology of Lung Cancer and Smoking (NCT00340340) | National Cancer Institute (NCI) | 2001-06-28 |
| The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography (NCT00420862) | Istituto Clinico Humanitas | 2001-06-01 |
| Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer (NCT00025571) | Roswell Park Cancer Institute | 2001-06-01 |
| Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers (NCT00900419) | University of Colorado, Denver | 2001-05-03 |
| Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia (NCT00127387) | The University of Texas Health Science Center at San Antonio | 2001-05-01 |
| Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer (NCT00897117) | Vanderbilt-Ingram Cancer Center | 2001-05-01 |
| Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer (NCT00016315) | Radiation Therapy Oncology Group | 2001-05-01 |
| Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants (NCT00899028) | Vanderbilt University Medical Center | 2001-05-01 |
| Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients (NCT00030771) | Swiss Cancer Institute | 2001-04-04 |
| A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer (NCT00144053) | West Japan Thoracic Oncology Group | 2001-04-01 |
| Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer (NCT00008333) | Alliance for Clinical Trials in Oncology | 2001-04-01 |
| A Study to Diagnose Lung Cancer by Sputum Cytology (01-312) (NCT00210080) | Merck Sharp & Dohme LLC | 2001-04-01 |
| Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer (NCT00021112) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-04-01 |
| Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking (NCT00021138) | Personal Improvement Computer Systems | 2001-04-01 |
| Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NCT00010218) | Alliance for Clinical Trials in Oncology | 2001-04-01 |
| Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer (NCT00079287) | Japan Multinational Trial Organization | 2001-03-01 |
| Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery (NCT00006470) | Radiation Therapy Oncology Group | 2001-03-01 |
| Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers (NCT00020878) | Jonsson Comprehensive Cancer Center | 2001-03-01 |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors (NCT00027638) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer (NCT00014196) | SWOG Cancer Research Network | 2001-03-01 |
| Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer (NCT00006349) | Alliance for Clinical Trials in Oncology | 2001-02-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer (NCT00006012) | Alliance for Clinical Trials in Oncology | 2001-02-01 |
| Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer (NCT00016211) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-02-01 |
| Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20) (NCT00310232) | Ontario Clinical Oncology Group (OCOG) | 2001-02-01 |
| Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00023985) | Roswell Park Cancer Institute | 2001-01-01 |
| Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer (NCT00008385) | ECOG-ACRIN Cancer Research Group | 2000-12-18 |
| Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment (NCT00016237) | EMD Serono | 2000-12-01 |
| Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer (NCT00653250) | Vanderbilt-Ingram Cancer Center | 2000-12-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer (NCT00006981) | National Cancer Institute (NCI) | 2000-12-01 |
| Docetaxel in Treating Patients With Non-Small Cell Lung Cancer (NCT00022022) | Istituto Nazionale per lo Studio e la Cura dei Tumori | 2000-12-01 |
| Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer (NCT00008372) | City of Hope Medical Center | 2000-12-01 |
| Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction (NCT00009789) | Alliance for Clinical Trials in Oncology | 2000-12-01 |
| Ultrathin Bronchoscopy for Solitary Pulmonary Nodules (NCT02490059) | University of Zurich | 2000-11-01 |
| Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung Cancer (NCT00193245) | SCRI Development Innovations, LLC | 2000-11-01 |
| Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09 (NCT00955175) | Cancer Trials Ireland | 2000-11-01 |
| Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer (NCT00009971) | National Cancer Institute (NCI) | 2000-11-01 |
| Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00278460) | Wake Forest University Health Sciences | 2000-11-01 |
| Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer (NCT00193310) | SCRI Development Innovations, LLC | 2000-11-01 |
| BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment (NCT00014547) | Theradex | 2000-11-01 |
| Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer (NCT00006484) | SWOG Cancer Research Network | 2000-11-01 |
| Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer (NCT00017407) | Ionis Pharmaceuticals, Inc. | 2000-10-13 |
| T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy (NCT00022243) | Tularik | 2000-10-01 |
| S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer (NCT00006487) | SWOG Cancer Research Network | 2000-10-01 |
| Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers (NCT00185913) | Stanford University | 2000-09-01 |
| Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer (NCT00031785) | Wake Forest University Health Sciences | 2000-09-01 |
| S9925: Collecting and Storing Samples From Patients With Lung Cancer (NCT00920010) | SWOG Cancer Research Network | 2000-09-01 |
| Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer (NCT00006004) | Eastern Cooperative Oncology Group | 2000-08-22 |
| Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00019929) | National Cancer Institute (NCI) | 2000-08-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer (NCT00006458) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 2000-08-01 |
| Lung Screening Study (NCT00006382) | National Cancer Institute (NCI) | 2000-08-01 |
| Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer (NCT00006347) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 2000-08-01 |
| Oltipraz in the Prevention of Lung Cancer in People Who Smoke (NCT00006457) | Northwestern University | 2000-08-01 |
| INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer (NCT00008255) | Memorial Sloan Kettering Cancer Center | 2000-08-01 |
| Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer (NCT00588263) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00020267) | National Cancer Institute (NCI) | 2000-07-01 |
| Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia (NCT00005880) | British Columbia Cancer Agency | 2000-07-01 |
| Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00017459) | Sanofi | 2000-07-01 |
| Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer (NCT00006877) | Case Comprehensive Cancer Center | 2000-07-01 |
| Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer (NCT00006370) | Novartis Pharmaceuticals | 2000-07-01 |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (NCT00900094) | University of Michigan Rogel Cancer Center | 2000-06-01 |
| Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs (NCT00020124) | National Institutes of Health Clinical Center (CC) | 2000-06-01 |
| Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer (NCT00006017) | Case Comprehensive Cancer Center | 2000-05-01 |
| Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer (NCT00006344) | Virginia Commonwealth University | 2000-05-01 |
| Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer (NCT00006019) | Memorial Sloan Kettering Cancer Center | 2000-05-01 |
| Lung Cancer Biomarkers and Screening (NCT00301119) | NYU Langone Health | 2000-05-01 |
| Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer (NCT00006082) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-05-01 |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer (NCT00005972) | Alliance for Clinical Trials in Oncology | 2000-05-01 |
| Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-Smokers (NCT00897364) | University of Colorado, Denver | 2000-05-01 |
| ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00006049) | AstraZeneca | 2000-05-01 |
| Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer (NCT00024076) | Jonsson Comprehensive Cancer Center | 2000-05-01 |
| ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00006048) | AstraZeneca | 2000-05-01 |
| Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer (NCT00006229) | NCIC Clinical Trials Group | 2000-04-04 |
| Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer (NCT00005849) | University of Chicago | 2000-04-01 |
| Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00005646) | Alliance for Clinical Trials in Oncology | 2000-04-01 |
| Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer (NCT00005032) | University of Chicago | 2000-04-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer (NCT00005858) | University of Maryland, Baltimore | 2000-04-01 |
| Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00005865) | GlaxoSmithKline | 2000-04-01 |
| Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer (NCT00416689) | Alliance for Clinical Trials in Oncology | 2000-04-01 |